Amylyx Pharmaceuticals, Inc. (AMLX)
13.81
-0.24
(-1.71%)
USD |
NASDAQ |
Mar 20, 16:00
13.82
+0.01
(+0.07%)
After-Hours: 20:00
Amylyx Pharmaceuticals Research and Development Expense (Quarterly) : 21.10M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Disc Medicine, Inc. | 46.14M |
| Cytokinetics, Inc. | 101.54M |
| Ionis Pharmaceuticals, Inc. | 279.36M |
| MediciNova, Inc. | 1.539M |
| Scholar Rock Holding Corp. | 46.45M |